Another investigation focused on the activity of CAR-NKT cells through host CD8+ T cell cross-priming and demonstrated that CD19.28z-CAR NKT cells have a dose-dependent cytotoxic effect on CD19-expressing luciferase-transduced A20-lymphoma cells. Here, CD19 is linked to lymphoma.